Executive Director
Amgen Inc
• At Amgen Vijay serves as a Clinical Pharmacology Oncology Therapeutic Area Leader: Leads a group of Clinical Pharmacologists direct reports responsible for Clinical Pharmacology & Pharmacometric leadership to Oncology Global Drug Development teams
• At Amgen he also lead a group of experts as direct reports in Mechanistic-PBPK Modeling & Simulation.
• Vijay has 17+ years industry Clinical Pharmacology & Pharmacometrics experience for both Small Molecule (SM) & Therapeutic Proteins (TP) development across TAs Oncology, Inflammation, CV/Metabolic diseases
• Vijay has significant contributions to global filings/approvals of following marketed SM & TP drugs: ONGLYZA®, KOMBOGLYZE®, KOMBIGLYZE XR®, ELIQUIS®, KYPROLIS®, BLINCYTO®
• He is trained as Pharmacist & earned PhD in PK/PD, Biopharmaceutics from University of Maryland School of Pharmacy
• Vijay serves on Editorial Boards: CPT; JCP; Clin Pharmacokinet
• He is a Fellow of ACCP; & IQ Consortium Clinical Pharmacology Leadership Group Amgen representative
• Vijay serves as Affiliate Assistant Professor University of Maryland School of Pharmacy; & as Industry Advisory Board Member College of Pharmacy Pharmaceutical Sciences, Washington State University
• He has authored 40+ scientific journal articles & 50+ scientific abstracts in field of Clinical Pharmacology & Pharmacometrics